{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:34:38Z","timestamp":1783002878212,"version":"3.54.5"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008637","name":"National Cancer Institute Center for Strategic Scientific Initiatives","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.it.2026.02.007","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:28:12Z","timestamp":1773235692000},"page":"246-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor-derived cystatin C enables amyloid clearance"],"prefix":"10.1016","volume":"47","author":[{"given":"Joseph","family":"Zambelas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8991-7824","authenticated-orcid":false,"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2026.02.007_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e1442","article-title":"Inverse association between cancer and Alzheimer\u2019s disease: results from the Framingham Heart Study","volume":"344","author":"Driver","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.it.2026.02.007_bb0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1212\/WNL.0b013e31829c5ec1","article-title":"Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study","volume":"81","author":"Musicco","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.it.2026.02.007_bb0015","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cell.2025.12.020","article-title":"Peripheral cancer attenuates amyloid pathology in Alzheimer\u2019s disease via cystatin-c activation of TREM2","volume":"189","author":"Li","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.it.2026.02.007_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2026.02.007_bb0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2\u2014a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.it.2026.02.007_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2026.02.007_bb0035","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0319-23.2024","article-title":"Lecanemab and donanemab as therapies for Alzheimer's disease: an illustrated perspective on the data","author":"Espay","year":"2024","journal-title":"eNeuro"},{"key":"10.1016\/j.it.2026.02.007_bb0040","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/ng.2007.23","article-title":"Cystatin C modulates cerebral beta-amyloidosis","volume":"39","author":"Kaeser","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2026.02.007_bb0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/ng.2007.29","article-title":"Cystatin C inhibits amyloid-beta deposition in Alzheimer\u2019s disease mouse models","volume":"39","author":"Mi","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2026.02.007_bb0050","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/archneur.57.11.1579","article-title":"Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease","volume":"57","author":"Finckh","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.it.2026.02.007_bb0055","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2026.02.007_bb0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1474-4422(19)30139-5","article-title":"Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial","volume":"18","author":"Boxer","year":"2019","journal-title":"Lancet Neurol."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490626000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490626000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:36:46Z","timestamp":1777617406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490626000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1471490626000384"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2026.02.007","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-derived cystatin C enables amyloid clearance","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2026.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}